Intracellular trafficking of TREM2 is regulated by presenilin 1

[1]  Carlos Cruchaga,et al.  Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms , 2016, eLife.

[2]  Lino C. Gonzalez,et al.  TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia , 2016, Neuron.

[3]  Huaxi Xu,et al.  Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation , 2016, Neurobiology of Aging.

[4]  J. Hardy,et al.  The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.

[5]  J. Walter,et al.  Functional involvement of γ-secretase in signaling of the triggering receptor expressed on myeloid cells-2 (TREM2) , 2016, Journal of Neuroinflammation.

[6]  K. Blennow,et al.  Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease , 2016, Molecular Neurodegeneration.

[7]  Manasi Malik,et al.  Genetics ignite focus on microglial inflammation in Alzheimer’s disease , 2015, Molecular Neurodegeneration.

[8]  M. Farzan,et al.  The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E* , 2015, The Journal of Biological Chemistry.

[9]  S. Younkin,et al.  Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)* , 2015, The Journal of Biological Chemistry.

[10]  Huaxi Xu,et al.  TREM2 in CNS homeostasis and neurodegenerative disease , 2015, Molecular Neurodegeneration.

[11]  C. Heyser,et al.  Appoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy Pathogenesis , 2015, Neuron.

[12]  O. Korvatska,et al.  R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study. , 2015, JAMA neurology.

[13]  Huaxi Xu,et al.  DAP12 Stabilizes the C-terminal Fragment of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) and Protects against LPS-induced Pro-inflammatory Response* , 2015, The Journal of Biological Chemistry.

[14]  S. Kang,et al.  Disease‐Associated Mutations of TREM2 Alter the Processing of N‐Linked Oligosaccharides in the Golgi Apparatus , 2015, Traffic.

[15]  S. Lincoln,et al.  TREM2 is associated with increased risk for Alzheimer’s disease in African Americans , 2015, Molecular Neurodegeneration.

[16]  D. Holtzman,et al.  TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model , 2015, Cell.

[17]  B. Strooper,et al.  Learning by failing: ideas and concepts to tackle γ-secretases in Alzheimer's disease and beyond. , 2015 .

[18]  Huaxi Xu,et al.  The γ-secretase complex: from structure to function , 2014, Front. Cell. Neurosci..

[19]  S. Lipton,et al.  Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease , 2014, Molecular Neurodegeneration.

[20]  B. Dubois,et al.  Homozygous TREM2 mutation in a family with atypical frontotemporal dementia , 2014, Neurobiology of Aging.

[21]  J. Molinuevo,et al.  TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis , 2014, Science Translational Medicine.

[22]  S. Sorbi,et al.  Heterozygous TREM2 mutations in frontotemporal dementia , 2014, Neurobiology of Aging.

[23]  A. Pestronk,et al.  TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. , 2014, JAMA neurology.

[24]  P. L. Fernández,et al.  Microglia receptors and their implications in the response to amyloid β for Alzheimer’s disease pathogenesis , 2014, Journal of Neuroinflammation.

[25]  P. Deyn,et al.  Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia , 2014, Neurobiology of Aging.

[26]  R. Kacimi,et al.  Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Deficiency Attenuates Phagocytic Activities of Microglia and Exacerbates Ischemic Damage in Experimental Stroke , 2015, The Journal of Neuroscience.

[27]  Jennifer M. Pocock,et al.  Insights into TREM2 biology by network analysis of human brain gene expression data , 2013, Neurobiology of Aging.

[28]  H. Neumann,et al.  Sequential Proteolytic Processing of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Protein by Ectodomain Shedding and γ-Secretase-dependent Intramembranous Cleavage* , 2013, The Journal of Biological Chemistry.

[29]  Jason J. Corneveaux,et al.  Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease , 2013, Neurobiology of Aging.

[30]  R. Petersen,et al.  neurodegeneration : evidence for association of the p . R 47 H variant with frontotemporal dementia and Parkinson ¿ s disease Permalink , 2013 .

[31]  C. Cruchaga,et al.  TREM2 is associated with the risk of Alzheimer's disease in Spanish population , 2013, Neurobiology of Aging.

[32]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[33]  M. Daly,et al.  Variant TREM2 as risk factor for Alzheimer's disease. , 2013, The New England journal of medicine.

[34]  A. Hofman,et al.  Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.

[35]  A. Singleton,et al.  Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. , 2012, JAMA neurology.

[36]  K. Mirnics,et al.  A Role for Presenilins in Autophagy Revisited: Normal Acidification of Lysosomes in Cells Lacking PSEN1 and PSEN2 , 2012, Journal of Neuroscience.

[37]  D. Westaway,et al.  Lysosomal Proteolysis and Autophagy Require Presenilin 1 and Are Disrupted by Alzheimer-Related PS1 Mutations , 2010, Cell.

[38]  B. de Strooper,et al.  Role of Presenilins in Neuronal Calcium Homeostasis , 2010, The Journal of Neuroscience.

[39]  Fred H. Gage,et al.  Mechanisms Underlying Inflammation in Neurodegeneration , 2010, Cell.

[40]  W. Seaman,et al.  A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia , 2009, Journal of neurochemistry.

[41]  Ian Parker,et al.  SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production. , 2008, The Journal of general physiology.

[42]  F. LaFerla,et al.  SERCA pump activity is physiologically regulated by presenilin and regulates amyloid β production , 2008, The Journal of cell biology.

[43]  Huaxi Xu,et al.  Pathological and physiological functions of presenilins , 2006, Molecular Neurodegeneration.

[44]  H. Neumann,et al.  Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2 , 2005, The Journal of experimental medicine.

[45]  R. Spreafico,et al.  Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia , 2004, The European journal of neuroscience.

[46]  Raphael Kopan.  Faculty Opinions recommendation of Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. , 2003 .

[47]  M. Colonna.  TREMs in the immune system and beyond , 2003, Nature Reviews Immunology.

[48]  Michael S. Wolfe,et al.  γ-Secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[49]  B. Strooper,et al.  Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex , 2003, Neuron.

[50]  P. Greengard,et al.  Presenilin-1 Regulates Intracellular Trafficking and Cell Surface Delivery of β-Amyloid Precursor Protein* , 2003, The Journal of Biological Chemistry.

[51]  J. Sutcliffe,et al.  Heterogeneous expression of the triggering receptor expressed on myeloid cells‐2 on adult murine microglia , 2002, Journal of neurochemistry.

[52]  M. Colonna,et al.  A Dap12-Mediated Pathway Regulates Expression of Cc Chemokine Receptor 7 and Maturation of Human Dendritic Cells , 2001, The Journal of experimental medicine.

[53]  D. Selkoe,et al.  Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity , 1999, Nature.

[54]  D. Borchelt,et al.  Effects of PS1 Deficiency on Membrane Protein Trafficking in Neurons , 1998, Neuron.

[55]  D. Borchelt,et al.  Endoproteolysis of Presenilin 1 and Accumulation of Processed Derivatives In Vivo , 1996, Neuron.

[56]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[57]  J. McCarthy,et al.  Beyond γ-secretase activity: The multifunctional nature of presenilins in cell signalling pathways. , 2016, Cellular Signalling.

[58]  B. Strooper,et al.  Learning by Failing: Ideas and Concepts to Tackle gamma-Secretases in Alzheimer's Disease and Beyond , 2015 .

[59]  A. Pestronk,et al.  TREM 2 Variant p . R 47 H as a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis , 2014 .

[60]  A. Ramasamy,et al.  Insights into TREM 2 biology by network analysis of human brain gene expression data , 2013 .

[61]  M. Arfan Ikram,et al.  Variant of TREM 2 Associated with the Risk of Alzheimer ’ s Disease , 2012 .

[62]  B. de Strooper,et al.  Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. , 2003, Neuron.

[63]  M. Colonna,et al.  A DAP 12-mediated Pathway Regulates Expression of CC Chemokine Receptor 7 and Maturation of Human Dendritic Cells , 2001 .

[64]  G. Glenner,et al.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.

[65]  S. Lincoln,et al.  TREM2 is associated with increased risk for Alzheimer’s disease in African Americans , 2015, Molecular Neurodegeneration.